| 1 |
35118652 | Pharmacologic induction of PGC-1α stimulates fetal haemoglobin gene expression. | 2022 Apr |
2 |
| 2 |
33956057 | Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease. | 2021 May 11 |
1 |
| 3 |
32987729 | Characterization of Hematopoiesis in Sickle Cell Disease by Prospective Isolation of Stem and Progenitor Cells. | 2020 Sep 24 |
1 |
| 4 |
29419425 | Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results. | 2018 May |
3 |
| 5 |
30322708 | The in vitro growth of a cord blood-derived cell population enriched for CD34+ cells is influenced by its cell cycle status and treatment with hydroxyurea. | 2018 Nov |
1 |
| 6 |
28447889 | Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD Patients. | 2017 Sep |
3 |
| 7 |
25808664 | Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation. | 2015 Jul |
1 |
| 8 |
16939808 | Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells. | 2006 Sep |
1 |
| 9 |
16125985 | Collection of blood stem cells from patients with sickle cell anemia. | 2005 Nov-Dec |
1 |
| 10 |
10997885 | Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythaemia vera and essential thrombocythaemia. | 2000 Mar |
1 |